Bacterial resistance to penicillins and cephalosporins

Author:

Abstract

The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtieth anniversary of the introduction of penicillin into medicine it seemed to me that it would be appropriate to consider primarily the changes which have taken place over this period in the incidence of resistance and the knowledge which has been gained concerning the nature of resistance to this family of antibiotics. Before we look at what the changes in resistance have been, however, it may be useful to consider what one means by the word resistant, and in fact one uses the word in two rather different ways. Used in one sense the term applies to those species of bacteria which are characteristically insensitive to penicillin, for example one may say that Pseudomonas aeruginosa is resistant to benzylpenicillin, because this is a characteristic of the species. On the other hand, the term resistant is also applied to particular strains of species of bacteria which are typically penicillin sensitive, or at least were typically sensitive at the time penicillin was first introduced into medicine, for example penicillin-resistant strains of staphylococci and penicillinresistant gonococci. As a result of these two uses of the word resistant some anomalies appear to arise. For example, strains of Escherichia coli inhibited by ampicillin at a concentration of 2 μg/ml would certainly be considered sensitive, whereas strains of gonococci inhibited by one-tenth of this concentration would be regarded as resistant and this is because typical sensitive strains are inhibited by even lower levels. Again, strains of P s . aeruginosa requiring for inhibition a concentration of gentamicin of 10 μg/ml would be said to be resistant, but strains inhibited by carbenicillin at a level as high as 50 μg/ml are considered sensitive. Here the reason is toxicity: a level of 10 μg/ml of gentamicin could not safely be maintained in the body, whereas a level of 50 μg/ml carbenicillin can. Clearly there are two criteria for judging organisms to be resistant, one is that the concentration of drug required to inhibit growth is a level which cannot readily be achieved at the site of infection and the other is simply that the minimum inhibitory concentration is significantly higher than that of the majority of strains of that particular species. Resistance to penicillins and cephalosporins, as with other antibiotics, may arise in bacteria in one of two ways. Resistance may occur as a result of chromosomal mutation or it may arise as a result of the transfer of genetic information from a resistant bacterial cell to a sensitive cell and this transfer may take place by transformation or by conjugation or by the phage mediated process of transduction. Resistant strains, once they arise, may be at a selectional advantage when the drug is used and as a result they may become more prevalent. The frequency at which antibiotic resistant strains arise, and the rate at which they subsequently increase in numbers, varies greatly with different antibiotics and different pathogens and some of the changes in bacterial resistance to penicillins which have occurred over the past 30 years are shown in diagrammatic form in figure 1.

Publisher

The Royal Society

Subject

General Medicine

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields;Drug Target Insights;2024-05-10

2. Antimicrobial Drug Efflux Pumps in Pseudomonas aeruginosa;Efflux-Mediated Antimicrobial Resistance in Bacteria;2016

3. Preface to the Second Edition;Evolution in Health and Disease;2007-11-22

4. Contributors;Evolution in Health and Disease;2007-11-22

5. Copyright Page;Evolution in Health and Disease;2007-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3